UNSPSC 51172446: Bismuth subsalicylate/codeine/kaolin/pectin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA208. This VA Drug Class (GA208) classifies this compound as belonging to the group ANTIDIARRHEAL AGENTS.

UNSPSC 51172446 Bismuth subsalicylate/codeine/kaolin/pectin is a Commodity code that encompasses specific pharmaceutical formulations; however, recent state and local opportunities tagged under this code show minimal direct relevance to the discrete product. The Collin County Community Supervision and Corrections Department RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026, does not procure this formulation but rather laboratory screening and confirmation testing capabilities with an estimated contract value of $600,000 over two years with optional renewal. The Texas Health and Human Services Commission's RFI HHS0017013 on direct-to-manufacturer prescriptions and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, focus on broader pharmaceutical supply chains and purchasing mechanisms rather than this specific bismuth-codeine-kaolin-pectin combination. None of these opportunities directly request the named Commodity formulation.

The issuing-body mix spans state health agencies (Texas HHS), county criminal justice departments (Collin County CSCD), and state cooperative purchasing alliances (MMCAP, administered by the Minnesota Department of Administration). Geographic activity concentrates in Texas and Minnesota with Oregon participation in the MMCAP cooperative. The code shows little relevant recent activity aligned with the specific Commodity formulation itself; the tagged opportunities represent general pharmaceutical procurement, testing services, and cooperative supply-chain vehicles rather than solicitation for this discrete drug combination. State and local buyers pursuing this Commodity are advised to validate direct relevance before pursuing opportunities initially tagged under this code.